Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors.
第一作者:
S M,Eschmann
第一单位:
Department of Nuclear Medicine, University of Tübingen, Otfried-Mueller-Strasse 14, 72076, Tübingen, Germany. susanne-martina.eschmann@med.uni-tuebingen.de
作者:
主题词
成年人(Adult);老年人(Aged);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);女(雌)性(Female);氟脱氧葡萄糖F18(Fluorodeoxyglucose F18);人类(Humans);发病率(Incidence);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);正电子发射断层显像术(Positron-Emission Tomography);预后(Prognosis);放射性药物(Radiopharmaceuticals);结果可重复性(Reproducibility of Results);危险性评估(Risk Assessment);危险因素(Risk Factors);敏感性与特异性(Sensitivity and Specificity);存活率(Survival Rate);治疗结果(Treatment Outcome)
DOI
10.1007/s00259-006-0197-0
PMID
16896660
发布时间
2019-12-10
- 浏览16
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文